NCT07031401

Brief Summary

Individuals with Chronic Obstructive Pulmonary Disease need the help and support of caregivers in issues such as limitations in their physical and social functions, inadequacy, social isolation, dependency, and continuing their daily lives. The World Health Organization (WHO) defines traditional medicine as knowledge, skills, and practices based on beliefs, experiences, and theories used for the prevention, diagnosis, recovery, and treatment of physical and mental disorders. Since traditional medicine varies from culture to culture, it covers different, unique treatments and practices of countries and even regions within countries. In some countries, these practices (CAM) are called 'alternative' and 'complementary'. There has been an increase in the use of complementary medicine in the last 30 years in developed and developing countries. While modern medical practices are used due to the supportive nature of complementary medicine, it is also used for purposes such as relaxing the patient, strengthening their immunity, and improving their psychological state. Patients diagnosed with COPD sometimes resort to alternative treatments. In parallel with the increase in life expectancy, the increase in chronic diseases such as COPD, which are difficult to care for and treat, the inability of healthcare professionals to allocate enough time, the suspicion of modern methods and possible side effects have greatly increased the interest in GETAT methods. The decrease in exercise capacity of COPD patients, frequent infection attacks, muscle weakness, and the accompanying anxiety and depression in these patients can be counted as reasons for increasing GETAT use. In light of this information, it was aimed to examine the attitudes of individuals with COPD towards GETAT use? Research Questions; What is the GETAT use status of individuals with COPD? What are the attitudes of individuals with COPD towards GETAT?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 22, 2025

Completed
23 days until next milestone

Study Start

First participant enrolled

July 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 3, 2025

Status Verified

June 1, 2025

Enrollment Period

3 months

First QC Date

June 11, 2025

Last Update Submit

August 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Title: Determination of attitudes of individuals with COPD toward the use of Traditional and Complementary Medicine (TCM)

    Description: Assessment of participants' attitudes toward Traditional and Complementary Medicine (GETAT in Turkish), using a validated attitude scale. The total attitude score will reflect the level of positivity or negativity in participants' perspectives.Time Frame: One-time assessment during data collectionAssessment Tool: Traditional and Complementary Medicine Attitude Scale (or equivalent validated tool in Turkish)Unit of Measure: Total attitude score (Likert scale)

    6 months from the start of the study

Secondary Outcomes (1)

  • Frequency and type of TCM methods used by individuals with COPD

    6 months from the start of the study

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

250

You may qualify if:

  • Chronic Obstructive Pulmonary Disease
  • Must be 18 years or older
  • Must be contactable

You may not qualify if:

  • \*Those who are unable to communicate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University

Merkez, Kütahya, 43200, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2025

First Posted

June 22, 2025

Study Start

July 15, 2025

Primary Completion

October 25, 2025

Study Completion

December 1, 2025

Last Updated

September 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations